Corvex, Inc. (MOVE) Q1 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings, and welcome to the Movano Health Q1 2024 earnings call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star and then zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Jay Kogan. Thank you. You may begin. Thanks, operator. Good afternoon, everyone, and thank you for joining us today. Milano Health CEO, John Master-Tataro, will open today's call with prepared remarks about the progress the company has made during the first quarter of 2024 in recent weeks. I will then provide highlights of the company's quarterly operating results and current financial position. Then we'll open up the call for Q&A. John and I will be joined by our Chief Marketing Officer, Tyler Booker, our Vice President of Business Development, Michael Soule, and Vice President of Product and Strategy, Stacey Salvi. Movano Health issued a news release this afternoon detailing first quarter 2024 financial results. Before we begin, I'd like to remind everyone that the company will make forward-looking statements during today's call based on current expectations. Whether in prepared remarks or during the Q&A session, these forward-looking statements are subject to inherent risk and uncertainties, and actual results may be materially different from such statements. These risks and uncertainties are detailed in the risk factors section of Movano Health's filings with the Securities and Exchange Commission, specifically in the company's forms 10Q and 10K. Except as otherwise required by federal securities laws, Movano Health disclaims any obligation to update ...